These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35573047)

  • 1. Pharmacological interventions enhance virus-free generation of
    Kath J; Du W; Pruene A; Braun T; Thommandru B; Turk R; Sturgeon ML; Kurgan GL; Amini L; Stein M; Zittel T; Martini S; Ostendorf L; Wilhelm A; Akyüz L; Rehm A; Höpken UE; Pruß A; Künkele A; Jacobi AM; Volk HD; Schmueck-Henneresse M; Stripecke R; Reinke P; Wagner DL
    Mol Ther Methods Clin Dev; 2022 Jun; 25():311-330. PubMed ID: 35573047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing.
    Balke-Want H; Keerthi V; Gkitsas N; Mancini AG; Kurgan GL; Fowler C; Xu P; Liu X; Asano K; Patel S; Fisher CJ; Brown AK; Tunuguntla RH; Patel S; Sotillo E; Mackall CL; Feldman SA
    Mol Cancer; 2023 Jun; 22(1):100. PubMed ID: 37365642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression.
    Mueller KP; Piscopo NJ; Forsberg MH; Saraspe LA; Das A; Russell B; Smerchansky M; Cappabianca D; Shi L; Shankar K; Sarko L; Khajanchi N; La Vonne Denne N; Ramamurthy A; Ali A; Lazzarotto CR; Tsai SQ; Capitini CM; Saha K
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36382633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Mediated Non-Viral Site-Specific Gene Integration and Expression in T Cells: Protocol and Application for T-Cell Therapy.
    Odé Z; Condori J; Peterson N; Zhou S; Krenciute G
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32604839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-viral
    Braun T; Pruene A; Darguzyte M; Vom Stein AF; Nguyen PH; Wagner DL; Kath J; Roig-Merino A; Heuser M; Riehm LL; Schneider A; Awerkiew S; Talbot SR; Bleich A; Figueiredo C; Bornhäuser M; Stripecke R
    Front Immunol; 2023; 14():1086433. PubMed ID: 37033919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-efficiency of genetic modification using CRISPR/Cpf1 system for engineered CAR-T cell therapy.
    Ding R; Chao CC; Gao Q
    Methods Cell Biol; 2022; 167():1-14. PubMed ID: 35152989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.
    Eyquem J; Mansilla-Soto J; Giavridis T; van der Stegen SJ; Hamieh M; Cunanan KM; Odak A; Gönen M; Sadelain M
    Nature; 2017 Mar; 543(7643):113-117. PubMed ID: 28225754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of ζ-deficient CARs into the
    Kath J; Franke C; Drosdek V; Du W; Glaser V; Fuster-Garcia C; Stein M; Zittel T; Schulenberg S; Porter CE; Andersch L; Künkele A; Alcaniz J; Hoffmann J; Abken H; Abou-El-Enein M; Pruß A; Suzuki M; Cathomen T; Stripecke R; Volk HD; Reinke P; Schmueck-Henneresse M; Wagner DL
    bioRxiv; 2023 Nov; ():. PubMed ID: 38116030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells.
    Glaser V; Flugel C; Kath J; Du W; Drosdek V; Franke C; Stein M; Pruß A; Schmueck-Henneresse M; Volk HD; Reinke P; Wagner DL
    Genome Biol; 2023 Apr; 24(1):89. PubMed ID: 37095570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T Cells.
    Hale M; Lee B; Honaker Y; Leung WH; Grier AE; Jacobs HM; Sommer K; Sahni J; Jackson SW; Scharenberg AM; Astrakhan A; Rawlings DJ
    Mol Ther Methods Clin Dev; 2017 Mar; 4():192-203. PubMed ID: 28345004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic priming of GD2
    Cappabianca D; Pham D; Forsberg MH; Bugel M; Tommasi A; Lauer A; Vidugiriene J; Hrdlicka B; McHale A; Sodji QH; Skala MC; Capitini CM; Saha K
    Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101249. PubMed ID: 38699288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia.
    Hu Y; Zhou Y; Zhang M; Ge W; Li Y; Yang L; Wei G; Han L; Wang H; Yu S; Chen Y; Wang Y; He X; Zhang X; Gao M; Yang J; Li X; Ren J; Huang H
    Clin Cancer Res; 2021 May; 27(10):2764-2772. PubMed ID: 33627493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated generation of gene-edited CAR T cells at clinical scale.
    Alzubi J; Lock D; Rhiel M; Schmitz S; Wild S; Mussolino C; Hildenbeutel M; Brandes C; Rositzka J; Lennartz S; Haas SA; Chmielewski KO; Schaser T; Kaiser A; Cathomen T; Cornu TI
    Mol Ther Methods Clin Dev; 2021 Mar; 20():379-388. PubMed ID: 33575430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic priming of GD2
    Cappabianca D; Pham D; Forsberg MH; Bugel M; Tommasi A; Lauer A; Vidugiriene J; Hrdlicka B; McHale A; Sodji Q; Skala MC; Capitini CM; Saha K
    bioRxiv; 2024 Mar; ():. PubMed ID: 38562720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells.
    MacLeod DT; Antony J; Martin AJ; Moser RJ; Hekele A; Wetzel KJ; Brown AE; Triggiano MA; Hux JA; Pham CD; Bartsevich VV; Turner CA; Lape J; Kirkland S; Beard CW; Smith J; Hirsch ML; Nicholson MG; Jantz D; McCreedy B
    Mol Ther; 2017 Apr; 25(4):949-961. PubMed ID: 28237835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized two-step electroporation process to achieve efficient nonviral-mediated gene insertion into primary T cells.
    Yang M; Tkach D; Boyne A; Kazancioglu S; Duclert A; Poirot L; Duchateau P; Juillerat A
    FEBS Open Bio; 2022 Jan; 12(1):38-50. PubMed ID: 34510816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-viral expression of chimeric antigen receptors with multiplex gene editing in primary T cells.
    Cappabianca D; Li J; Zheng Y; Tran C; Kasparek K; Mendez P; Thu R; Maures T; Capitini CM; Deans R; Saha K
    Front Bioeng Biotechnol; 2024; 12():1379900. PubMed ID: 38882639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of T
    Madison BB; Patil D; Richter M; Li X; Tong M; Cranert S; Wang X; Martin R; Xi H; Tan Y; Weiss L; Marquez K; Coronella J; Shedlock DJ; Ostertag EM
    Mol Ther Nucleic Acids; 2022 Sep; 29():979-995. PubMed ID: 36189080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR.
    Stenger D; Stief TA; Kaeuferle T; Willier S; Rataj F; Schober K; Vick B; Lotfi R; Wagner B; Grünewald TGP; Kobold S; Busch DH; Jeremias I; Blaeschke F; Feuchtinger T
    Blood; 2020 Sep; 136(12):1407-1418. PubMed ID: 32483603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources.
    Schmidts A; Marsh LC; Srivastava AA; Bouffard AA; Boroughs AC; Scarfò I; Larson RC; Bedoya F; Choi BD; Frigault MJ; Bailey SR; Leick MB; Vatsa S; Kann MC; Prew MS; Kleinstiver BP; Joung JK; Maus MV
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32900862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.